dehydroepiandrosterone acetate

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 12/01/2007 - "A series of novel 1H- and 2H-indazole derivatives of the commercially available dehydroepiandrosterone acetate have been synthesized and tested for inhibition of human cytochrome 17alpha-hydroxylase-C(17,20)-lyase (CYP17), androgen receptor (AR) binding affinity, and cytotoxic potential against three prostate cancer (PC) cell lines."
2.	Fatty Liver 10/01/1998 - "Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats." 12/01/1999 - "20 electron microscopic cytochemistry of peroxisomes in suppression of fatty liver by dehydroepiandrosterone-acetate, phenobarbital, and/or clofibrate"
3.	Body Weight (Weight, Body) 10/01/1986 - "Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats."

1.	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)
2.	Androgen Receptors (Androgen Receptor)
3.	Cytochromes
4.	Phenobarbital (Luminal)
5.	Orotic Acid
6.	Clofibrate